Neonc Technologies (NASDAQ:NTHI) Posts Earnings Results, Misses Estimates By $0.16 EPS

Posted by George Bondi on May 15th, 2026

Neonc Technologies (NASDAQ:NTHI – Get Free Report) posted its earnings results on Friday. The company reported ($0.38) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.16), Zacks reports.

Neonc Technologies Stock Performance

Shares of NTHI stock traded up $0.04 during mid-day trading on Friday, reaching $5.50. 52,043 shares of the stock traded hands, compared to its average volume of 66,114. The stock’s fifty day simple moving average is $6.42 and its two-hundred day simple moving average is $8.18. Neonc Technologies has a 1-year low of $3.20 and a 1-year high of $12.99.

Insider Activity at Neonc Technologies

In other news, President Amir F. Heshmatpour purchased 10,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $4.16 per share, with a total value of $41,600.00. Following the completion of the purchase, the president owned 3,072,000 shares of the company’s stock, valued at $12,779,520. This trade represents a 0.33% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders bought 80,700 shares of company stock worth $423,590 over the last quarter.

Institutional Trading of Neonc Technologies

A number of hedge funds have recently made changes to their positions in the company. Barclays PLC raised its position in shares of Neonc Technologies by 5,314.8% during the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after acquiring an additional 8,982 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in shares of Neonc Technologies during the fourth quarter worth about $124,000. OMERS ADMINISTRATION Corp bought a new stake in Neonc Technologies in the fourth quarter worth approximately $126,000. Royal Bank of Canada bought a new stake in Neonc Technologies in the first quarter worth approximately $247,000. Finally, State Street Corp increased its holdings in Neonc Technologies by 9.9% in the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after purchasing an additional 3,900 shares in the last quarter.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. BTIG Research started coverage on Neonc Technologies in a research note on Friday, April 24th. They issued a “buy” rating and a $15.00 price objective on the stock. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $15.00.

Read Our Latest Analysis on Neonc Technologies

Neonc Technologies Company Profile

(Get Free Report)

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.